Careers
24 Jan, 2025 by Cherry Pascual
Royal Cargo, the leading specialized logistics provider in the Philippines, has further solidified its position as a premier healthcare logistics and medical technology hub with the recent issuance of two (2) Licenses to Operate (LTOs) from the Food and Drug Administration (FDA) for its South Hub facility.
This significant achievement highlights the South Hub’s crucial role in the pharmaceutical and medical device sectors and underscores Royal Cargo’s commitment to delivering high-quality, compliant, and efficient services. While gearing up to establish an ecozone named “Medical and Logistics Solutions Ecozone,” Royal Cargo continues to enhance its value to healthcare supply chain businesses.
READ: Opportunities and Partnerships: PEZA Visits Royal Cargo Facility
On January 16, 2025, Royal Cargo South Hub received its FDA License to Operate as a Drug Manufacturer. This accreditation enables the facility to provide value-added services such as repacking and labeling pharmaceutical products and assisting pharmaceutical and cosmetics companies in meeting regulatory and market-specific packaging and label requirements. Additionally, on October 9, 2024, the facility secured its License to Operate as a Medical Devices Manufacturer, allowing Royal Cargo to offer specialized services, including repacking and packaging medical equipment and devices. This accreditation showcases the South Hub’s capabilities to ensure quality, compliance, and efficiency in handling critical healthcare products.
With these latest FDA approvals, Royal Cargo South Hub is well-positioned to drive growth in the healthcare logistics sector, as it offers a comprehensive suite of specialized services and infrastructure tailored explicitly to pharmaceutical and medical equipment and device manufacturers’ needs, making it ready to support the industry’s evolving demands.
© 2025 Royal Cargo. All Rights Reserved.
General Trading Conditions | Data Privacy Notice